GIR | n (%) | OR | 95% CI | p |
---|---|---|---|---|
Group I | ||||
 RDS | 10 (47.6) | 0.776 | 0.295–2.043 | 0.607 |
 NEC | 3 (14.3) | 1.944 | 0.443–8.538 | 0.372 |
 Sepsis | 1 (4.7) | 0.096 | 0.012–0.757 | 0.050 |
 ROP | 3 (14.3) | 1.643 | 0.386–6.994 | 0.498 |
 Pulmonary hypertension | 3 (14.3) | 1.944 | 0.443–8.538 | 0.372 |
 Hypoglycemia | 9 (42.9) | 4.000 | 1.384–11.565 | 0.008* |
Group II | ||||
 RDS | 37 (55.2) | 1.410 | 0.594–3.344 | 0.435 |
 NEC | 4 (5.9) | 0.317 | 0.079–1.280 | 0.093 |
 Sepsis | 22 (32.8) | 2.444 | 0.824–7.250 | 0.101 |
 ROP | 7 (10.4) | 1.050 | 0.252–4.373 | 0.947 |
 Pulmonary hypertension | 5 (7.5) | 0.524 | 0.130–2.109 | 0.257 |
 Hypoglycemia | 11 (16.4) | 0.393 | 0.145–1.065 | 0.062 |
 Hyperglycemia | 9 (13.4) | 1.009 | 0.285–3.575 | 0.989 |
Group III | ||||
 RDS | 4 (44.5) | 0.698 | 0.176–2.774 | 0.608 |
 NEC | 2 (22.2) | 3.306 | 0.574–19.043 | 0.160 |
 Sepsis | 4 (44.5) | 2.261 | 0.559–9.151 | 0.243 |
 ROP | 0 (0.0) | 1.115 | 1.039–1.198 | 0.286 |
 Pulmonary hypertension | 1 (11.1) | 1.250 | 0.138–11.307 | 0.842 |
 Hyperglycemia | 2 (22.2) | 2.000 | 0.368–10.879 | 0.415 |